Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 474

PDF Downloaded: 323


Get Permission Jain, Gupta, and Porwal: A study on the clinical profile of patients with thyroid-related orbitopathy presenting to a tertiary eye care institute


Introduction

Thyroid-associated ophthalmopathy is an autoimmune disorder that is the most frequent extrathyroidal involvement of Graves’ disease but sometimes occurs in euthyroid or hypothyroid patients.1 Patient’s quality of life could be affected even by mild disease.2 TED is more common in females. Males and advancing age are at a higher risk of severe disease.3 TED is estimated to affect between 155 and 250 people per 100,000 of the overall population.4 The prevalence of TED among patients with thyroid dysfunction ranges from 34.7% to 51.7%.5 For predisposition to Graves ophthalmopathy, environmental (Smoking, selenium deficiency, vitamin D deficiency) and genetic factors (Family history of thyroid disease) are also important.6, 7 To assess the clinical manifestations of TED there are many classification systems like Werner’s NO SPECS classification (No physical signs or symptoms, only signs, Soft tissue involvement, Proptosis, Extraocular muscle signs, Corneal involvement, and Sight loss).8 Clinical Activity Score (CAS) is a classification system for TED to determine the treatment according to the severity and progression of the disease.9, 10 Patients with Thyroid-associated disease present with chemosis, superior limbic keratoconjunctivitis, proptosis, lid retraction and oedema, restricted extraocular muscle, and dysthyroid optic neuropathy.11

Aims and Objectives

To analyse the demographic profile and clinical manifestations of TED in patients presenting to a tertiary care hospital in Ajmer, Rajasthan.

Materials and Methods

This study was an observational cross-sectional which included all 95 patients from all age groups who attended the Outpatient Department of a Tertiary Care Hospital, Ajmer, with signs and symptoms of thyroid-associated orbitopathy or diagnosed with thyroid-associated orbitopathy with no history of multiple endocrine disorder, after taking informed consent. Complete ocular examinations including visual acuity, colour vision, assessment for different lid signs, anterior segment examination by slit lamp, intraocular pressure measurement, fundus examination, extraocular movement, and exophthalmometry by Herterl’s exophthalmometer were performed. General systemic examination and blood investigations like CBC, ESR, T3, T4, and TSH were also done. Based on the ocular examination Clinical Activity Score (CAS) was calculated to determine the treatment and progression of the disease.

Results

The mean age of study participants was 43.93± 12.25 years. Age ranges from 21 years to 80 years. Maximum number of cases was in the age group 41 to 50 years (36.8%). The majority of participants were Female (62.1%). Bi-lateral proptosis was present in 84.4% of cases. Among all patients 69 (72.6%) were hyperthyroid, 19 (20.0%) were euthyroid and 7 (7.4%) were euthyroid. 5 (5.2%) presented with dysthyroid optic neuropathy. 42.1% active TED (Onset< 12 months) patients and 57.8% inactive TED (Onset> 12 months) patients with no correlation with age at presentation. In active TED findings such as Average CAS (2.30), dysthyroid optic neuropathy 5(100%), average Hertel’s value (21.97±2.39), and presenting signs like proptosis lower lid retraction were significantly higher as compared to inactive TED (Table 1). Two-thirds (70%) of active cases were observed to be silent presenters (Onset >12 months and CAS≤3) and 30% to be clinically active group (Onset< 12 months and CAS≥4); having a statistically significant correlation with age. Average Hertel’s exophthalmometry value, dysthyroid optic neuropathy was significantly higher in the clinically active Group compared to the silent presenters (Table 2).

Table 1

Comparison of demographic and clinical profile of thyroid eye disease (Ted) patients when divided between active TED (N = 40) and inactive TED (N = 55)

Active TED

Inactive TED

P Value

Definition

Onset< 12 months

Onset >12 months

Number

40 (42.10%)

55(57.8%)

Average age at presentation

45.64

43.67

>0.05 (NS)

Average CAS

2.30

0.5

<0.001 (S)

Dysthyroid Optic Neuropathy

5 (100%)

0 (0%)

0.026 (S)

Average Hertel Value

21.97± 2.39

19.75± 1.28

<0.001 (S)

Proptosis

33 (73.3%)

12(26.6%)

<0.001 (S)

Lower lid retraction

16 (66.6%)

8 (33.3%)

0.010 (S)

Table 2

Comparison of demographic and clinical profile of clinically active thyroid eye disease (TED) patients when divided between 2 groups: Clinically active group (N = 12) and silent presenters (N = 28)

Clinically active group (CAS≥4)

Silent Presenter (CAS≤3)

P Value

Definition

Onset< 12 months and CAS≥4

Onset >12 months and CAS≤3

Number

12 (30%)

28 (70%)

Average age at presentation

50.4

42.46

<0.001 (S)

Average CAS

4.2

1.57

<0.001 (S)

Dysthyroid Optic Neuropathy

4 (80%)

1 (20%)

0.009 (S)

Average Hertel Value

23.83± 2.75

21.02± 3.01

0.009 (S)

Figure 1

Showing Kocher’s sign (staring look and frightening appearance of eyes) with Dalrymple’s sign (LID Retraction) and chemosis

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/69f31908-b6d3-468e-b0d8-7f78e52dd60e/image/70804e05-b75e-4ee6-8c7d-9fcd7f3bb25b-uimage.png

Figure 2

Showing von Graefe’s sign (upper lid retraction on down gaze)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/69f31908-b6d3-468e-b0d8-7f78e52dd60e/image/33abfc9f-272a-4ad0-9d5f-40bd863d2d1e-uimage.png

Discussion

This study was an observational, cross-sectional study conducted in the Department of Ophthalmology, J.L.N. Medical College, Ajmer - a tertiary care centre with well-equipped facilities. The mean age of study participants in the current study was 43.93± 12.25 years. Since the majority of hyperthyroid patients are found in the age group 22-40 years, thyroid eye disease manifests late in these patients. Most of the cases were in the age group 41 to 50 years (36.8%) in the present study which is following the previous studies. Female to male ratio was 1.64:1, which shows female preponderance in this disease.12, 13 Ophthalmic findings are usually bilateral (84.4%), but may also be unilateral or asymmetric. Most of the patients have symptoms including dryness and stinging, photophobia, epiphora, diplopia, and a feeling of pressure behind the eyes. Watering and gritty sensation are the commonest presenting symptoms among the Indian population.12 Subclinical involvement is present in approximately 70% of patients with Graves’ hyperthyroidism. Expansion of the extraocular muscles may be apparent on magnetic resonance imaging (MRI) and computed tomography (CT). In approximately 3-5% of patients, the disease follows a severe course with severe pain, inflammation, sight-threatening corneal ulceration, and compressive optic neuropathy.14 Hyperthyroidism was found in 72.6% of cases. This implies that most of the cases were hyperthyroid in this study (nearly two-thirds). Most Hypothyroid patients had mild disease while most hyperthyroid patients had moderate to severe disease. In hypothyroid patients, milder symptoms like dry eye are common presenting symptoms.15 These symptoms can be missed if TED is not suspected in these patients. Earlier systemic involvement is more common in hypothyroid patients, unlike hyperthyroid patients where ocular involvement is more common earlier. 5(5.2%) cases had Dysthyroid optic neuropathy which is a serious sight-threatening complication commonly present in hyperthyroid patients. 42.1% active TED (Onset< 12 months) patients and 57.8% inactive TED (Onset> 12 months) patients with no correlation with age at presentation are seen. In active TED findings such as Average CAS (2.30), dysthyroid optic neuropathy 5(100%), average Hertel’s value (21.97±2.39), and presenting signs like proptosis lower lid retraction were significantly higher as compared to inactive TED. Treatment of TED patients is determined by CAS. If CAS is ≥3 steroids are prescribed in active TED.

Conclusion

Middle age group and female sex were the common clinical profile of the patients of TED. TED was the most frequently associated with Graves’ disease. Dry eye symptoms were commonly presenting symptoms. Hyperthyroid and active TED were risk factors for sight-threatening disease. 5 out of 95 cases were presented as Dysthyroid Optic Neuropathy which is the most sight-threatening complication of TED. Early diagnosis, appropriate treatment and close follow-up are necessary as TED may lead to sight-threatening conditions.

Source of Funding

None.

Conflict of Interest

None.

References

1 

NM Hodgson F Rajaii Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic ReviewOphthalmol Ther2020912133

2 

KP Cockerham L Padnick-Silver N Stuertz M Francis-Sedlak RJ Holt Quality of Life in Patients with Chronic Thyroid Eye Disease in the United StatesOphthalmol Ther202110497587

3 

4 

M Abraham-Nordling K Byström O Törring M Lantz G Berg J Calissendorff Incidence of hyperthyroidism in SwedenEur J Endocrinol20111656905

5 

SL Lim AKE Lim M Mumtaz E Hussein WMW Bebakar Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' diseaseThyroid200818121297301

6 

M Ardley T McCorquodale H Lahooti B Champion JR Wall Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunityThyroid Res2012514

7 

C Marcocci GJ Kahaly GE Krassas L Bartalena M Prummel M Stahl Selenium and the course of mild Graves’ orbitopathyN Engl J Med201136420192031

8 

SC Werner Classification of the eye changes of Graves' diseaseAm J Ophthalmol19696846468

9 

MP Mourits L Koornneef WM Wiersinga MF Prummel A Berghout RV DerGaag Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approachBr J Ophthalmol198973863944

10 

A Muralidhar S Das S Tiple Clinical profile of thyroid eye disease and factors predictive of disease severityIndian J Ophthalmol2020688162934

11 

E Şahlı K Gündüz Thyroid-associated OphthalmopathyTurk J Ophthalmol201747294105

12 

AK Khurana S Sunder BK Ahluwalia KC Malhotra S Gupta A clinico-investigative profile in Graves’ ophthalmopathyIndian J Ophthalmol1992402568

13 

NC Lim G Sundar S Amrith KO Lee Thyroid eye disease: a Southeast Asian experienceBr J Ophthalmol20159945128

14 

MC Comert S Yilmaz AY Tas A Sahin The Effect of Thyroid Eye Disease on Corneal Biomechanical PropertiesBeyoglu Eye J2022731938

15 

M Wong WJ Inder Alternating hyperthyroidism and hypothyroidism in Graves’ diseaseClin Case Rep20186916848



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

641-644


Authors Details

Sakshi Jain*, Ayushi Gupta, Rakesh Porwal


Article History

Received : 22-06-2023

Accepted : 21-07-2023


Article Metrics


View Article As

 


Downlaod Files